Cranberry trials recruiting now

3 registrations that name cranberry as a study arm and are recruiting or about to, as ClinicalTrials.gov listed them on Oct 20, 2026. Read each listing for its full criteria and current status.

Kymata never assesses eligibility. Each listing names its own criteria; only its study team can say whether someone can join. Trial doses are given under the trial's monitoring and are not a schedule for anyone outside it.

Filter 3 registrations

Status

1US sites across 1 state

All 3 registrations

RecruitingNCT07453537

Cranberry Polyphenols and Stress Resilience During Multitasking in Healthy Adults

  • No phase
  • University of Florida
  • About 84 people
  • Starts Aug 1, 2026 (estimated)

In plain words A study of cranberry in people 30 to 55, run by University of Florida. It plans to enroll about 84 people at 1 US site.

Who it lists and where

Who the trial lists, as registered

Lists people 30 to 55; healthy volunteers accepted. Conditions: Stress Response; Mental Stress; Multitasking Behavior and Multitasking Ability; Physiological Stress; Cognitive Symptoms; Motor Activity.

  • At least 110 pounds
  • Between 30 and 55 years
  • BMI between 18.9 and 29.9 kg/m²
  • A minimum education level of high school or above

The exclusion criteria are on the listing.

What it tests, as registered

Cranberry juice; Placebo juice

Registered summary

This randomized, double-blind, placebo-controlled clinical trial evaluates whether 70 days of daily cranberry juice consumption improves cognitive performance and motor accuracy and reduces psychological and physiological stress responses during a motor-cognitive dual-task multitasking challenge in healthy adults aged 30-55 (Aim 1). It is hypothesized that chronic cranberry juice intake will enhance dual-task performance and attenuate stress reactivity (Hypothesis 1). The full summary is on the listing.

Where, as registered

1 US site in 1 state.

RecruitingNCT07393126

Effects of the Consumption of Test Product on Urination in Healthy Japanese Adults

  • No phase
  • Indena S.p.A
  • About 76 people
  • Started Dec 8, 2025

In plain words A study of cranberry in people 18 and older, run by Indena S.p.A. It plans to enroll about 76 people at 2 sites, none in the US.

Who it lists and where

Who the trial lists, as registered

Lists people 18 and older; healthy volunteers accepted. Conditions: Healthy Japanese.

  • Japanese
  • Men or women
  • Adults
  • Healthy individuals

3 more inclusion criteria and the exclusion criteria are on the listing.

What it tests, as registered

Cranberry Phospholipids; Placebo

Registered summary

The goal of this clinical trial is to test in Japanese adults who experience concerns regarding urinary frequency. The main question it aims to answer is: •Does consumption of Cranberry Phospholipids reduce daytime urinary frequency? Participants will be given the following tasks: * Take two tablets daily containing Cranberry Phospholipid for eight weeks. * Answer the questionnaire on the overactive bladder (OAB)-specific quality of life (QOL). * Answer the questionnaire on OAB symptoms. * Answer the questionnaire on urinary frequency during the study period. The full summary is on the listing.

Where, as registered

No US site; Japan (2).

RecruitingNCT07460856

Effects of Cranberry on Gut and Metabolic Health

  • No phase
  • Laval University
  • About 73 people
  • Started Jul 7, 2025

In plain words A study of cranberry in people 25 to 70, run by Laval University. It plans to enroll about 73 people at 1 site, none in the US.

Who it lists and where

Who the trial lists, as registered

Lists people 25 to 70; healthy volunteers accepted. Conditions: Overweight/Obesity; Metabolic Syndrome; Insulin Resistance; Microbiota.

  • body mass index between 25 and 40 kg/m2
  • at least one of the following criteria: fasting plasma insulin >60 pmol/L, fasting glycemia between 5.5 and 6.9 mmol/L, glycated hemoglobin (HbA1c) level of 5.7- 6.4% and/or fasting triglyceride >1.35 mmol/L.

The exclusion criteria are on the listing.

What it tests, as registered

Cranberry beverage; Placebo beverage

Registered summary

The consumption of plant-based foods, particularly berries, has been associated with improved health due to their high content of bioactive compounds. Among these, polyphenols-especially proanthocyanidins (PACs)-may offer protective effects against chronic diseases related to overweight and obesity. Cranberries are naturally rich in PACs and may positively influence metabolic health by modulating the gut microbiota. However, their specific effects on intestinal integrity and broader metabolic outcomes remain underexplored. The full summary is on the listing.

Where, as registered

No US site; Canada (1).

ClinicalTrials.gov lists 6 open registrations for this search, including ones where cranberry is not a study arm or that are past the 3 we keep. Search them on ClinicalTrials.gov (opens in new tab).

Educational only. Not medical advice. Some links earn us a commission: kymatahealth.com/affiliate-disclosure.